Cyclin-dependent kinase inhibitor SU9516 enhances sensitivity to methotrexate in human T-cell leukemia Jurkat cells

  • UCHIYAMA Hitoji
    Department of Molecular-Targeting Cancer Prevention, Department of Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine
  • SOWA Yoshihiro
    Department of Molecular-Targeting Cancer Prevention, Department of Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine
  • WAKADA Miki
    Department of Molecular-Targeting Cancer Prevention, Department of Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine
  • YOGOSAWA Mayumi
    Department of Molecular-Targeting Cancer Prevention, Department of Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine
  • NAKANISHI Ryoko
    Department of Molecular-Targeting Cancer Prevention, Department of Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine
  • HORINAKA Mano
    Department of Molecular-Targeting Cancer Prevention, Department of Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine
  • SHIMAZAKI Chihiro
    Division of Hematology and Oncology, Department of Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine
  • TANIWAKI Masafumi
    Division of Hematology and Oncology, Department of Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine
  • SAKAI Toshiyuki
    Department of Molecular-Targeting Cancer Prevention, Department of Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine

Search this article

Journal

References(46)*help

See more

Details 詳細情報について

Report a problem

Back to top